Business Wire

IDC MarketScape Positions TreviPay as a Major Player in Worldwide Accounts Receivable Automation Applications for the Enterprise

Share

TreviPay, the most-trusted B2B payments and invoicing network, today announced it has been named a Major Player in the IDC MarketScape: Worldwide Accounts Receivable Automation Applications for the Enterprise 2024 Vendor Assessment1. TreviPay was one of the 14 vendors with a SaaS or cloud offering to be evaluated for their accounts receivable (A/R) strategy and capabilities.

The IDC MarketScape report highlighted a selection of TreviPay’s strengths including:

  • Robust APIs: “The TreviPay suite of APIs enables merchants to directly integrate invoicing into any ecommerce platform, point-of-sale environment, or order management platform. In addition, TreviPay enables a white-labeled solution that may be embedded within the checkout, giving buyers a line of sight into how much credit they have available in real time. Terms to buyer and settlement with client are both independently configurable, enabling guaranteed DSO.”
  • Expanding/Expansive Ecosystem: “The most recent investments include a strategic partnership with Mastercard to give suppliers the ability to extend trade credit financing and invoicing using Mastercard's commercial card payment capabilities. Also, TreviPay recently announced a strategic partnership with Allianz Trade that integrates Allianz Trade's credit insurance into TreviPay solution for enhanced risk management that enables funding capabilities.”

The evaluation assesses vendors in two primary categories: strategies and capabilities. The strategy criteria measure how well the vendor’s future strategy aligns with what customers will require over the next three to five years, and measures functionality roadmap, extensibility, scalability, customer experience and 3rd platform strategy. And the capabilities criteria assess agility, automation, extensibility, flexibility, functionality, portfolio benefits, 3rd platform usage, and visibility.

“Traditional accounts receivable processes are ripe for disruption. As we saw in our vendor assessment, this is dynamic market with a range of A/R solutions for the enterprise, but only a few, like TreviPay, that offer an integrated order-to-cash solution along with native financing options,” said Kevin Permenter, senior research director, Financial Applications at IDC.

This recognition follows TreviPay’s recent news to expand its automated order-to-cash offering and further enhance the buyer onboarding experience by reducing manual reviews and speeding up credit decisioning to near real-time. It also comes on the heels of the TreviPay Crossroads conference which brought together clients, partners and industry leaders from across the B2B payments ecosystem.

“We are thrilled to be recognized by IDC MarketScape as a Major Player in Accounts Receivable Automation Applications for the Enterprise report noting our deep payment management functionality, robust APIs and expansive ecosystem as key strengths,” said Brandon Spear, CEO of TreviPay. “As a first-time participant in this evaluation, it is particularly gratifying to see our distinctive capabilities and forward-looking strategies recognized in this assessment. With our focus on working with the largest global brands, we have seen the massive opportunity in automating core A/R processes, offering more payment choice to buyers and providing perfect DSO to financial teams.”

Download an excerpt of the vendor assessment.

1 IDC, IDC MarketScape: Worldwide Accounts Receivable Automation Applications for the Enterprise 2024 Vendor Assessment, #US51740924, December 2024

About TreviPay

At TreviPay, we believe loyalty begins at the payment. By understanding the diverse and unique requirements of B2B sellers, TreviPay’s global B2B payments and invoicing network enables enterprises to provide payments choice and convenience, open new markets and automate accounts receivables. With more than four decades of experience, TreviPay serves leaders looking to build loyalty while driving efficiency and embracing new digital channels, especially in industries with large distribution networks such as manufacturing, retail, and transportation. For more information, visit www.trevipay.com.

About IDC MarketScape

IDC MarketScape vendor assessment model is designed to provide an overview of the competitive fitness of technology and service suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241204578799/en/

Contacts

Alissa Clayton
The Fletcher Group
647.390.9085
alissa@fletchergroupllc.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Pacific Avenue Capital Partners Establishes Paris France Office and Xavier Lambert Joins as Head of Europe to Lead Firm’s EU Expansion10.12.2024 08:00:00 CET | Press Release

Pacific Avenue Capital Partners, LLC (“Pacific Avenue”), a Los Angeles-headquartered private equity firm focused on corporate divestitures, carve-outs, and other complex situations in the middle market, announced today the opening of a European office in Paris, France. The office will be led by Xavier Lambert, who joins the firm as Managing Director – Head of Europe. Opening a Paris office underscores Pacific Avenue's continued focus on being a solutions provider to corporate sellers globally. With increasing carve-out and divestiture activity globally, and a growing number of Pacific Avenue’s deals with international operations, establishing a presence in Europe is a natural step in fulfilling the firm’s strategy. The addition of Mr. Lambert will expand the firm’s international footprint and add capabilities to serve global corporate sellers and Pacific Avenue businesses with international operations. "Expanding our footprint in Europe marks a pivotal milestone in Pacific Avenue’s gro

Media Release: Allianz lifts financial ambitions at its Capital Markets Day 202410.12.2024 07:07:00 CET | Press Release

Outperforming on key 2024 financial targets, Allianz has set ambitious financial targets through 2027 at its Capital Markets Day 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241209829384/en/ Oliver Bäte, Chief Executive Officer of Allianz SE (Photo: Allianz SE) In a world of uncertainty, Allianz aims to capitalize on its role as a trusted partner of choice by growing its customer base with innovative protection and retirement solutions and seamless services. Allianz will focus on three levers to sustain its strong value creation momentum. First, driving smart growth by winning new customers, increasing cross-sell, and reducing churn. Second, reinforcing productivity through continuous delivery of its productivity agenda, also leveraging latest generative AI solutions. Third, strengthening business and financial resilience, supported by a refined capital management framework. Oliver Bäte, Chief Executive Officer of Al

Sirius Therapeutics Announces Promising Phase I Clinical Data from Its Factor XI siRNA, a Long-Acting Next-Generation Anticoagulant for Thromboembolic Disorders10.12.2024 05:00:00 CET | Press Release

Sirius Therapeutics today announced promising preliminary data from its Phase 1 first-in-human clinical trial of SRSD107, a next generation siRNA therapeutics under clinical development for the prevention and treatment of thromboembolic disorders, such as myocardial infarction, ischemic stroke, and venous thromboembolism. The trial data were presented during a poster session at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, held in San Diego, CA. SRSD107 is designed to inhibit Factor XI (FXI), a protein in the coagulation pathway that has shown potential to reduce thrombosis without significantly increasing the risk of bleeding, a major liability of current drugs. “In this trial, SRSD107 was safe and well tolerated, with pharmacokinetic parameters consistent with a typical siRNA product,” said Dr. Patrick Yue, Sirius’ Chief Medical Officer. “We are encouraged by the marked, prolonged reduction in FXI antigen and activity, and increase in clotting, or throm

Mori Memorial Foundation Issues GPCI – 2024 and GPCI – Financial Centers Reports:10.12.2024 04:00:00 CET | Press Release

The Mori Memorial Foundation’s Institute for Urban Strategies, a research body established by Mori Building, Tokyo’s leading urban landscape developer, today released its Global Power City Index (GPCI) 2024 report on the overall strength of the world’s 48 major cities. For the second time, the report additionally includes the 'GPCI–Financial Centers' index. This index reflects the growing importance of measures taken by major cities to enhance their status as international financial centers, capturing changes in their financial and business environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241209714811/en/ The 48 major cities evaluated in Mori Memorial Foundation’s GPCI–2024 Report (Graphic: Business Wire) More than 18 months have elapsed since the World Health Organization declared an end to the COVID-19 pandemic in May 2023. With the resurgence of economic activity, mobility and the expansion of international to

BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA ® and Novel Pipeline Assets10.12.2024 02:30:00 CET | Press Release

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that plans to change its name to BeOne Medicines Ltd., today announced the presentation of new clinical data at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, underscoring its leadership in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) through continued clinical success with BRUKINSA® (zanubrutinib) and promising advancements in its pipeline assets. “The breadth of data we’re presenting at ASH underscores BRUKINSA’s role as a best-in-class treatment for CLL and highlights BeiGene’s leadership in advancing the treatment landscape for B-cell malignancies,” said Mehrdad Mobasher, M.D., M.P.H., Chief Medical Officer, Hematology at BeiGene. “BRUKINSA shows tremendous promise for patients as a monotherapy and as a backbone for best-in-class combinations. The combination of BRUKINSA and our investigational BCL2 inhibitor, sonrotoclax, demonstrated significant pot

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye